Finance

Lists
Why is MRKR up 13,04%?
Dive Deeper
MRKR:NASDAQ
Marker Therapeutics Inc
1,04 $
+13,04%
(+0,12) 1D
1,01 $
-2,44% (-0,025)
After hours
Closed: 16 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRKR...
Open
1,02 $
High
1,20 $
Low
1,00 $
Mkt. cap
17,43 մլն
Avg. vol.
77,05 հզր
Volume
1,15 մլն
52-wk high
2,46 $
52-wk low
0,84 $
EPS
-0,47 $
Beta
1,53
Shares outstanding
16,67 մլն
No. of employees
5
Open
1,02 $
High
1,20 $
Low
1,00 $
Mkt. cap
17,43 մլն
Avg. vol.
77,05 հզր
Volume
1,15 մլն
52-wk high
2,46 $
52-wk low
0,84 $
EPS
-0,47 $
Beta
1,53
Shares outstanding
16,67 մլն
No. of employees
5
News stories
From web sources and news partners
About Marker Therapeutics Inc
CEO-
Employees5
Founded1992
HeadquartersՀյուստոն, Տեխաս, Միացյալ Նահանգներ
Sector-
Websitemarkertherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to MRKR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MRKR in the last 3 months.
Highest
Current 1,04 $
10,00 $ (+861,54%)
Average
9,00 $ (+765,38%)
Lowest
8,00 $ (+669,23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
10,00 $
+861,5%
09/21/2026
John Newman
Canaccord Genuity
Buy
Maintained
8,00 $
+669,2%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,23 մլն
1,10 մլն
751,69 հզր
681,58 հզր
Cost of goods sold
2,35 մլն
2,14 մլն
2,84 մլն
1,48 մլն
Cost of revenue
2,35 մլն
2,14 մլն
2,84 մլն
1,48 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,02 մլն
846,61 հզր
1,23 մլն
1,14 մլն
Operating expense
1,02 մլն
846,61 հզր
1,23 մլն
1,14 մլն
Total operating expenses
3,37 մլն
2,99 մլն
4,07 մլն
2,62 մլն
Operating income
-2,14 մլն
-1,88 մլն
-4,07 մլն
-2,62 մլն
Other non operating income
-
-
760,37 հզր
681,58 հզր
EBT including unusual items
-2,00 մլն
-1,72 մլն
-3,18 մլն
-1,83 մլն
EBT excluding unusual items
-2,00 մլն
-1,72 մլն
-3,18 մլն
-1,83 մլն
Income tax expense
-
-15,16 հզր
-
-
Effective tax rate
-
0,88%
-
-
Other operating expenses
-
-
-
-
Net income
-2,00 մլն
-1,70 մլն
-3,18 մլն
-1,83 մլն
Net profit margin
-162,11%
-154,35%
-
-
Earnings per share
-0,12
-0,04
-0,16
-0,09
Interest and investment income
138,06 հզր
165,63 հզր
132,89 հզր
112,56 հզր
Interest expense
-
-
-
-
Net interest expenses
138,06 հզր
165,63 հզր
132,89 հզր
112,56 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps